A balanced portfolio
serving a global industry —
balanced industry sector distribution
The pharmaceutical, medical technology and biotechnology industries are global businesses. Companies are increasingly looking beyond national borders for scientific collaborations, funding opportunities, R&D partnerships and merger possibilities. GLSV tries to identify and support companies that have the potential to become leaders in their markets. To maximise possible returns on investments and manage risk, GLSV also tries to ensure a balanced industry sector distribution that reflects the trends in technological innovation. A global perspective is provided by syndicate partnerships with leading US-based funds.